Emerging Immunomodulatory Therapies and New Treatment Paradigms for Axial Spondyloarthritis

The purpose of this review is to educate the reader about the evolving classification of axial spondyloarthritis (AxSpA) and describe recent treatment data from clinical trials of medications with mechanisms of action other than TNF inhibition. The review will also address emerging treatment strategies for AxSpA. New and more sensitive classification schema for AxSpA find that the prevalence of the disease is more than twice that of the historic...